Literature DB >> 16106214

Visualization of newly deposited tau in neurofibrillary tangles and neuropil threads.

Tomohiro Miyasaka1, Atsushi Watanabe, Yuko Saito, Shigeo Murayama, David M A Mann, Mineo Yamazaki, Rivka Ravid, Maho Morishima-Kawashima, Kazuo Nagashima, Yasuo Ihara.   

Abstract

Neurofibrillary tangles (NFTs) and neuropil threads (NTs), the major hallmark of Alzheimer disease (AD), are composed of the microtubule-associated protein tau that has undergone posttranslational modifications, including deamidation and isomerization on asparaginyl or aspartyl residues. Because such modifications represent protein aging, we generated 2 antibodies, TM4, specific for Asp-387 of tau, and iD387, specific for isoAsp-387 of tau, to investigate the evolution of NFTs and NTs. On Western blots of Sarkosyl-insoluble fractions, TM4 strongly labeled paired helical filament-tau (PHF-tau), whereas iD387 preferentially labeled PHF smear. Thus, it is reasonable to postulate that TM4-labeled tau (unmodified tau species) represents more recent deposition, and iD387-labeled tau (modified tau species) represents earlier deposition. Unexpectedly, TM4 immunostained even highly evolved NFTs, suggesting that deposition of newly produced tau continues until neuronal death. iD387 labeled the whole profile of NFTs up to distal dendritic branches, whereas TM4 staining was localized to particular portions of NFTs in proximal dendrites and neuronal perikarya. In NTs, TM4 preferentially labeled the outer portion, whereas iD387 intensely labeled the core portion. Based on TM4-positive NFT counts and total NFT counts, we speculate that NFTs in the human hippocampus are produced at a constant rate irrespective of the disease stage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106214     DOI: 10.1097/01.jnen.0000173890.79058.1d

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  16 in total

1.  Ubiquitin proteasome pathway-mediated degradation of proteins: effects due to site-specific substrate deamidation.

Authors:  Edward J Dudek; Kirsten J Lampi; Jason A Lampi; Fu Shang; Jonathan King; Yongting Wang; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-30       Impact factor: 4.799

2.  Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain.

Authors:  Atsuko Kubo; Shouyou Ueda; Ayaka Yamane; Satoko Wada-Kakuda; Mai Narita; Makoto Matsuyama; Akane Nomori; Akihiko Takashima; Taisuke Kato; Osamu Onodera; Motohito Goto; Mamoru Ito; Takami Tomiyama; Hiroshi Mori; Shigeo Murayama; Yasuo Ihara; Hiroaki Misonou; Tomohiro Miyasaka
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

Review 3.  The many faces of tau.

Authors:  Meaghan Morris; Sumihiro Maeda; Keith Vossel; Lennart Mucke
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

4.  Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease.

Authors:  Evan E Hubbard; Lilian R Heil; Gennifer E Merrihew; Jasmeer P Chhatwal; Martin R Farlow; Catriona A McLean; Bernardino Ghetti; Kathy L Newell; Matthew P Frosch; Randall J Bateman; Eric B Larson; C Dirk Keene; Richard J Perrin; Thomas J Montine; Michael J MacCoss; Ryan R Julian
Journal:  J Proteome Res       Date:  2021-11-24       Impact factor: 4.466

5.  Beyond Protein Sequence: Protein Isomerization in Alzheimer's Disease.

Authors:  Harrison Specht; Nikolai Slavov
Journal:  J Proteome Res       Date:  2022-02-04       Impact factor: 4.466

6.  C. elegans and Neurodegeneration In Caenorhabditis Elegans: Anatomy, Life Cycles and Biological Functions.

Authors:  Ebany J Martinez-Finley; Sudipta Chakraborty; Sam Caito; Stephanie Fretham; Michael Aschner
Journal:  Adv Med Biol       Date:  2012

7.  Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain.

Authors:  Ayaho Dan; Muneaki Takahashi; Masami Masuda-Suzukake; Fuyuki Kametani; Takashi Nonaka; Hiromi Kondo; Haruhiko Akiyama; Takao Arai; David M A Mann; Yuko Saito; Hiroyuki Hatsuta; Shigeo Murayama; Masato Hasegawa
Journal:  Acta Neuropathol Commun       Date:  2013-08-21       Impact factor: 7.801

8.  The homologous carboxyl-terminal domains of microtubule-associated protein 2 and TAU induce neuronal dysfunction and have differential fates in the evolution of neurofibrillary tangles.

Authors:  Ce Xie; Tomohiro Miyasaka; Satomi Yoshimura; Hiroyuki Hatsuta; Sawako Yoshina; Eriko Kage-Nakadai; Shohei Mitani; Shigeo Murayama; Yasuo Ihara
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

Review 9.  Tau protein modifications and interactions: their role in function and dysfunction.

Authors:  Anna Mietelska-Porowska; Urszula Wasik; Marcelina Goras; Anna Filipek; Grazyna Niewiadomska
Journal:  Int J Mol Sci       Date:  2014-03-18       Impact factor: 5.923

10.  Immunostaining of oxidized DJ-1 in human and mouse brains.

Authors:  Yoshiro Saito; Tomohiro Miyasaka; Hiroyuki Hatsuta; Kazuko Takahashi-Niki; Kojiro Hayashi; Yuichiro Mita; Osamu Kusano-Arai; Hiroko Iwanari; Hiroyoshi Ariga; Takao Hamakubo; Yasukazu Yoshida; Etsuo Niki; Shigeo Murayama; Yasuo Ihara; Noriko Noguchi
Journal:  J Neuropathol Exp Neurol       Date:  2014-07       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.